Photo of David B. McKinley
R United States House · District 1 · West Virginia

Rep. David B. McKinley

Compare
Total votes
958
all sessions
Attendance
89%
105 missed
Lower than 97% of chamber peers
With party
93%
of cast votes
Lower than 80% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Higher than 79% of chamber peers
Sponsored
640
bills & resolutions
Higher than 84% of chamber peers
Committees
0
assignments
640 bills and resolutions

Sponsored bills

Total
640
Primary
41
Co-sponsor
599
This page
640
matching current filters
Co-sponsor HR 695
In committee · United States House · Co-sponsor
USPS Fairness Act

USPS Fairness Act This bill repeals the requirement that the U.S. Postal Service annually prepay future retirement health benefits.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 702
In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 588
In committee · United States House · Co-sponsor
Stopping the Mental Health Pandemic Act

Stopping the Mental Health Pandemic Act This bill requires the Substance Abuse and Mental Health Services Administration to award grants to states, tribal nations, local governments, behavioral health and primary care providers, and community organizations to support behavioral health treatment and services during the COVID-19 (i.e., coronavirus disease 2019) pandemic.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 620
In committee · United States House · Co-sponsor
Dignity for Aborted Children Act

Dignity for Aborted Children Act This bill sets out requirements for the disposition of human fetal tissue from an abortion. Specifically, it requires abortion providers to obtain a patient's informed consent for one of two specified methods of disposition. First, patients may choose to retain possession of the tissue. A patient may choose to transfer the tissue to an entity that provides interment or cremation services. Second, in cases where the tissue is expelled on the provider’s premises, the patient may elect to release the tissue to the provider. Providers must ensure any tissue released to them is interred or cremated within seven days of the procedure in a manner consistent with state law regarding the disposal of human remains. Abortion providers must report annually about these requirements and other specified information. The bill provides civil or criminal penalties for violations of disposal, informed consent, and reporting requirements.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 541
In committee · United States House · Co-sponsor
Defund Planned Parenthood Act of 2021

Defund Planned Parenthood Act of 2021 This bill restricts federal funding for Planned Parenthood Federation of America Inc. or any of its affiliates or clinics for one year. Specifically, it prohibits funding those entities unless they certify that the affiliates and clinics will not perform, and will not provide funds to entities that perform, abortions during that year. If the certification requirement is not met, the Department of Health and Human Services and the Department of Agriculture must recoup any federal assistance received by those entities. However, the bill's funding restriction does not apply to abortions performed in cases of rape or incest or when necessary to resolve a physical condition that endangers a woman's life. The bill also provides additional funding for community health centers for the one-year period. These funds are subject to the same abortion-related restrictions and exceptions.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 554
In committee · United States House · Co-sponsor
SAVE Moms and Babies Act of 2021

Support And Value Expectant Moms and Babies Act of 2021 or the SAVE Moms and Babies Act of 2021 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 477
In committee · United States House · Co-sponsor
Ally’s Act

Ally's Act This bill requires private health insurance plans to cover certain hearing devices and systems (e.g., bone-anchored auditory implants) and related items and services. The bill also imposes limits on cost sharing.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 343
In committee · United States House · Co-sponsor
Taxpayer Conscience Protection Act of 2021

Taxpayer Conscience Protection Act of 2021 This bill establishes reporting requirements for states regarding certain Medicaid payments to abortion providers. Specifically, the bill requires states that make Medicaid payments using federal funds for any items or services furnished by an abortion provider to annually (1) submit a report to the Centers for Medicare & Medicaid Services on all such payments, and (2) publish the report on the state's website. The report must include specified information, including the number of abortions performed by the providers and the gestational age with respect to each such abortion.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 366
In committee · United States House · Co-sponsor
Protecting Access to Post-COVID–19 Telehealth Act of 2021

Protecting Access to Post-COVID-19 Telehealth Act of 2021 This bill makes permanent several telehealth flexibilities that were initially authorized during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019), particularly with respect to Medicare coverage of telehealth services. For example, the bill permanently allows federally qualified health centers and rural health clinics to serve as the distant site (i.e., the location of the health care practitioner) for telehealth services under Medicare. Payment must be made in the same manner as for non-telehealth services, rather than in accordance with a separate methodology determined by the Centers for Medicare & Medicaid Services (CMS). The bill also permanently allows beneficiaries to receive Medicare telehealth services at any site, regardless of type or location, and grants the CMS general authority to waive any other requirements during any emergency period.

In committee Feb 2, 2021 1 co-sponsor
Primary HR 280
In committee · United States House · Lead sponsor
PDMPs Help Patients Act of 2021

PDMPs Help Patients Act of 2021 This bill directs the Department of Health and Human Services (HHS) to establish a grant program to test the feasibility of integrating substance use disorder and behavioral health treatment locator tools into prescription drug monitoring programs. HHS may award grants to up to five states.

In committee Feb 2, 2021 0 co-sponsors
Showing 611 to 620 of 640 bills
Previous 1 … 61 62 63 … 64 Next